Your session is about to expire
What is Istodax
Effectiveness
When to interrupt dosage
The prescribed dosage of Istodax is contingent upon the diagnosed state. The quantity likewise fluctuates, in line with the method of administration cited in the table beneath.Warnings
There are 20 known major drug interactions with Istodax.Istodax Novel Uses: Which Conditions Have a Clinical Trial Featuring Istodax?
No current clinical trials are investigating the utility of Istodax in treating Lymphoma, Cutaneous T-Cell Disorders.Istodax Reviews: What are patients saying about Istodax?
Patient Q&A Section about istodax
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is istodax chemo?
"It is classified as a "topoisomerase II inhibitor." Istodax is a chemotherapy drug that inhibits topoisomerase II."
What is istodax used for?
"ISTODAX is a prescription medicine used to treat people with a type of cancer called cutaneous T-cell lymphoma (CTCL) or peripheral T-cell lymphoma (PTCL) after at least one other type of medicine by mouth or injection has been tried. It is not known if ISTODAX is effective in children under the age of 18."
Why was romidepsin taken off the market?
"Bristol Myers Squibb announced today that it is withdrawing romidepsin (Istodax) as a treatment option for patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) in the United States. This decision is based on the lack of beneficial effects of romidepsin identified in the confirmatory phase 3 Ro-CHOP trial (NCT01796002)."
How is istodax administered?
"Romidepsin is indicated as a treatment for cutaneous T-cell lymphoma for patients who have received at least one prior systemic therapy. The recommended dose is 14 mg/m2 administered intravenously over a 4-hour period on days 1, 8 and 15 of a 28-day cycle."